Advertisement
Advertisement
ATRC
AtriCure, Inc.
62.48
USDSponsored
+1.06
+1.73%
Oct 29, 15:59 UTC -4
Closed
After-Market
62.13
-0.35
-0.57%
AtriCure, Inc. (ATRC) Earnings
ATRC Earnings Reports
Positive Surprise Ratio
ATRC beat 33 of 43 last estimates.
77%
Next Report
Next Week
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$154.24M
/-$0.04
Implied change from Q2 26 (Revenue/ EPS)
+0.41%
/-122.22%
Implied change from Q3 25 (Revenue/ EPS)
+14.87%
/+300.00%
AtriCure, Inc. earnings per share and revenue
On Jul 23, 2026, ATRC reported earnings of 0.18 USD per share (EPS) for Q2 26, beating the estimate of 0.00 USD, resulting in a 3900.00% surprise. Revenue reached 153.60 million, compared to an expected 154.88 million, with a -0.82% difference. The market reacted with a +6.18% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 154.24 million USD, implying an decrease of -122.22% EPS, and increase of 0.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Abbott Laboratories
Report Date
Oct 21, 2026 For Q3 26
Estimate
$1.42
Actual
$1.42
Surprise
-0.68%
Stryker Corporation
Report Date
Oct 29, 2026 For Q3 26
Estimate
$3.58
Actual
$3.52
Surprise
-1.75%
Boston Scientific Corp.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.72
Actual
$0.73
Surprise
+1.05%
ResMed Inc.
Report Date
Oct 29, 2026 For Q1 27
Estimate
$2.69
Actual
$2.91
Surprise
+7.79%
GE HealthCare Technologies Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
$1.22
Actual
$1.34
Surprise
+9.13%
Baxter International Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.52
Actual
$0.57
Surprise
+10.86%
Sundial Growers Inc. Common Shares
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-101.26%
FAQ
What were AtriCure, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, AtriCure, Inc. reported EPS of $0.18, beating estimates by 3900%, and revenue of $153.60M, -0.82% below expectations.
How did the market react to AtriCure, Inc.'s Q2 2026 earnings?
The stock price moved up 6.18%, changed from $33.00 before the earnings release to $35.04 the day after.
When is AtriCure, Inc. expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for AtriCure, Inc.'s next earnings report?
Based on 11
analysts, AtriCure, Inc. is expected to report EPS of -$0.04 and revenue of $154.24M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.